Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Persica mouthwash versus normal saline for prevention of ventilator-associated respiratory infection in hospitalized children
IRCT20101207005335N2Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- May 2019
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Persica mouthwash in ventilator-associated pneumonia (VAP) and Ventilator-associated respiratory infection (VARI) (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Clinical pulmonary infection assessment, Body temperature and 5 more. Started May 2019; status: completed.
02
Drugs
Persica mouthwash
03
Conditions
ventilator-associated pneumonia (VAP)Ventilator-associated respiratory infection (VARI)
Beyond the preview
Go deeper on IRCT20101207005335N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20101207005335N2.